Skip to main content
Top

Tip

Swipe om te navigeren naar een ander hoofdstuk

2019 | OriginalPaper | Hoofdstuk

27. The menopause, the perimenopause and the postmenopause

Auteurs : drs. Dorenda K. E. van Dijken, Dr Maryam Kavousi, Monique M. A. Brood-van Zanten, Dr Loes Jaspers, Dr Mick A. A. van Trotsenburg

Gepubliceerd in: Textbook of Obstetrics and Gynaecology

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Summary

Menopause is a transition phase. Four out of five women experience some kind of discomfort and one third of these women experience serious complaints. Vasomotor symptoms are the most common complaints, but also menstrual disorders, mood swings, joint problems, urovaginal symptoms, or sexual disorders may occur. For these women the menopause has a serious impact on quality of life and consecutively societal consequences. Several treatment options are available. To date there is overwhelming scientific evidence that the benefits overweigh the risks of menopausal hormonal therapy (MHT). In the past, following the WHI study risks have been overrated or incorrectly interpreted. It is of importance that prescribing MHT should be individualised, based on the type of complaints, individual preferences and risks. Non-hormonal alternatives are available but merely not evidence-based, less effective and not always safe. For all women after menopause, healthy aging and prevention of chronic diseases is of the essence. Thus a life course approach can be of importance to make it possible to anticipate and so take prevention measures for chronic diseases with high morbidity and mortality risk, such as gender specific cardiovascular diseases and osteoporosis.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Woordenlijst
Menopause
The absence of menstrual periods for 12 consecutive months
Menopause transition
The transition from the reproductive age through to menopause
Premature ovarian insufficiency
A condition characterized by amenorrhoea, hypo-oestrogenism, and elevated serum gonadotropin levels in women younger than 40 years
Follicle stimulating hormone
A hormone, secreted by the anterior pituitary gland, which stimulates the development of ovarian follicles in the female and testicular function in the male
Luteinizing hormone
A gonadotropin (a hormone that affects the function of the sex organs) that is released by the pituitary gland in response to luteinizing hormone-releasing hormone
Body mass index
A key index for relating weight to height
Endometrial hyperplasia
A condition of excessive proliferation of the cells of the endometrium, or inner lining of the uterus 
Anti-Müllerian hormone
A glycoprotein hormone structurally related to inhibin and activin from the transforming growth factor beta superfamily, whose key roles are in growth differentiation and folliculogenesis
Vasomotor symptoms
Episodes of profuse heat accompanied by sweating and flushing
Depression
A state of low mood and aversion to activity that can affect a person’s thoughts, behaviour, feelings, and sense of well-being
Osteoporosis
Thinning of the bones, with reduction in bone mass, due to depletion of calcium and bone protein
Bone mineral density
A measure of bone density, reflecting the strength of bones as represented by calcium content
Life course approach
An approach developed for analyzing people’s lives within structural, social, and cultural contexts 
Literatuur
1.
go back to reference Hale GE, Zhao X, Hughes CL, et al. Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the staging of reproductive aging workshop (STRAW) staging system. J Clin Endocrinol Metab. 2007;92:3060–7. CrossRef Hale GE, Zhao X, Hughes CL, et al. Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the staging of reproductive aging workshop (STRAW) staging system. J Clin Endocrinol Metab. 2007;92:3060–7. CrossRef
2.
go back to reference Jaspers L. Health and aging in older adults: a gender-specific and life course perspective. Thesis, 2017. Jaspers L. Health and aging in older adults: a gender-specific and life course perspective. Thesis, 2017.
3.
go back to reference Kovacs G, Briggs P, Panay, N. Managing the Menopause. 21st Century Solutions. ISBN-13 : 9781107451827. Cambridge UK. Kovacs G, Briggs P, Panay, N. Managing the Menopause. 21st Century Solutions. ISBN-13 : 9781107451827. Cambridge UK.
12.
go back to reference Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2001;58(6):529–34. CrossRef Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2001;58(6):529–34. CrossRef
13.
go back to reference Villiers VT de, et al. Global consensus statement on menopausal hormone therapy. Climacteric 2013;16(3):316–37. Villiers VT de, et al. Global consensus statement on menopausal hormone therapy. Climacteric 2013;16(3):316–37.
14.
go back to reference Wallace WHB, Kelsey TW. Human ovarian reserve from conception to the menopause. PLoS One 2010;5(1):e8772. CrossRef Wallace WHB, Kelsey TW. Human ovarian reserve from conception to the menopause. PLoS One 2010;5(1):e8772. CrossRef
Metagegevens
Titel
The menopause, the perimenopause and the postmenopause
Auteurs
drs. Dorenda K. E. van Dijken
Dr Maryam Kavousi
Monique M. A. Brood-van Zanten
Dr Loes Jaspers
Dr Mick A. A. van Trotsenburg
Copyright
2019
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-368-2131-5_27